Tissue Regenix Group
Medical Equipment Manufacturing • 
Leeds, England, United Kingdom • 21-50 Employees
Company overview
| Headquarters | Unit one & two Astley Way, Swillington, Leeds, West Yorkshire LS26 8XT, GB |
| Phone number | +4412106599353 |
| Website | |
| NAICS | 3391 |
| SIC | 384 |
| Keywords | Development, Regenerative Medicine, Biotech, Orthobiologics |
| Founded | 2006 |
| Employees | 21-50 |
| Socials |
Key Contacts at Tissue Regenix Group
Daniel Lee
Chief Executive Officer
Jamie Freedman
Sr. Director, Contracts & Data Analytics
Kris Rowley
Technical & Operations Director
Kirsten Lund
Emea Business Director
Tissue Regenix Group Email Formats
Tissue Regenix Group uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@tissueregenix.com), used 68.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@tissueregenix.com | 68.8% |
{first initial}.{last name} | j.doe@tissueregenix.com | 25% |
{first initial}{last name} | jdoe@tissueregenix.com | 6.2% |
About Tissue Regenix Group
Tissue Regenix is a leading medical devices company in the field of regenerative medicine. Tissue Regenix was formed in 2006 when it was spun-out from the University of Leeds, UK. The company's patented decellularisation ('dCELL®') technology removes DNA and other cellular material from animal and human soft tissue leaving an acellular tissue scaffold which is not rejected by the patient's body and can then be used to repair diseased or worn out body parts. Current applications address many critical clinical needs such as sports medicine, heart valve replacement and wound care. In November 2012 Tissue Regenix Group plc set up a subsidiary company in the United States - 'Tissue Regenix Wound Care Inc.', rebranded 'TRX BioSurgery' in February 2018. January 2016 saw the establishment of joint venture GBM-V, a multi- tissue bank based in Rostock, Germany. In August 2017 Tissue Regenix acquired CellRight Technologies®, a biotech company that specializes in regenerative medicine and is dedicated to the development of innovative osteoinductive and wound care scaffolds that enhance healing opportunities of defects created by trauma and disease. CellRight's human osteobiologics may be used in spine, trauma, general orthopedic, foot & ankle, dental, and sports medicine surgical procedures.
Tissue Regenix Group revenue & valuation
| Annual revenue | $19,800,000 |
| Revenue per employee | $439,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $63,200,000 |
| Total funding | $17,800,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Tissue Regenix Group has 24 employees across 6 departments.
Departments
Number of employees
Tissue Regenix Group Tech Stack
Discover the technologies and tools that power Tissue Regenix Group's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
CMS
JavaScript libraries
PaaS
Load balancers
JavaScript libraries
Security
Miscellaneous
JavaScript frameworks
Miscellaneous
JavaScript libraries
Web frameworks
Italy
Sweden
Belgium
Frequently asked questions
4.8
40,000 users
